A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT04040192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Maintenance Treatment and Flare Reduction With Crisaborole Ointment, 2%, Once Daily Over 52 Weeks in Pediatric and Adult Participants (Ages 3 Months and Older) With Mild-to-Moderate Atopic Dermatitis, Who Responded to Twice Daily Crisaborole Ointment, 2%, Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate crisaborole therapy once daily (QD) as a long-term topical maintenance therapy for the reduction of flare in responders to crisaborole twice daily (BID) treatment.
Study identification
- NCT ID
- NCT04040192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 620 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Months and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 12, 2019 (Actual)
- Primary completion
- Jan 19, 2022 (Actual)
- Completion
- Jan 19, 2022 (Actual)
- Last update posted
- Mar 8, 2023
2019 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Asthma and Allergy Associates, PC | Colorado Springs | Colorado | 80907 | — |
| Colorado Springs Dermatology Clinic, PC | Colorado Springs | Colorado | 80910 | — |
| Skin Care Research LLC | Boca Raton | Florida | 33486 | — |
| Clinical Neuroscience Solutions, Inc | Jacksonville | Florida | 32256 | — |
| Olympian Clinical Research | Largo | Florida | 33770 | — |
| Baumann Cosmetic and Research Institute | Miami | Florida | 33137 | — |
| Clinical Neuroscience Solutions, Inc | Orlando | Florida | 32801 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| Meridian Clinical Research, LLC | Baton Rouge | Louisiana | 70808 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Skin Specialists PC | Omaha | Nebraska | 68144 | — |
| Ohio Pediatric Research Association, Inc. | Dayton | Ohio | 45414 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Oklahoma State University - Center for Health Sciences | Tulsa | Oklahoma | 74127 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| Innovate Research, LLC | Fort Worth | Texas | 76244 | — |
| Austin Institute for Clinical Research | Houston | Texas | 77056 | — |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | — |
| Center for Clinical Studies, LTD. LLP | Webster | Texas | 77598 | — |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | — |
| PI-Coor Clinical Research LLC | Burke | Virginia | 22015 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
| Principle Research Solutions | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04040192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04040192 live on ClinicalTrials.gov.